Pattern of Non Valvular Atrial Fibrillation in Acute Ischemic Stroke Patients at Assiut University Hospitals

September 23, 2019 updated by: Shery Refaat Asaad, Assiut University
Pattern of non valvular Atrial fibrillation in acute ischemic stroke patients at Assiut University Hospitals.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Percentage of patients with AF admitted with acute cerebrovascular stroke at Assuit University and correlation between AF and severity of stroke at admission and discharge.

Study Type

Observational

Enrollment (Anticipated)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Ayman khairy, assistatnt professor
  • Phone Number: 01094438055

Study Locations

      • Assiut, Egypt, 23123
        • Recruiting
        • Shery Refaat Asaad
        • Contact:
        • Contact:
          • Ayman khairy, assistant professor
          • Phone Number: 01094438055

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The study will include all cases of acute cerebrovascular stroke in Assiut university hospital

Description

Inclusion Criteria:

  • Patients presented with acute cerebrovascular stroke aged more than 18 years old.

Exclusion Criteria:

  1. Patients below 18 years old.
  2. Patient admitted with cerebral hemohrrage.
  3. Patients with significant valvular heart disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ischemic stroke patients
all patient admitted with acute ischemic stroke either their ECG was AF or sinus rythm
echocardiography for left atrial diameter, size ,Ejection Fraction Holter for detection of paroxusmal AF
Other Names:
  • holter

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of patients with AF admitted with acute cerebrovascular stroke at Assuit University.
Time Frame: 1 year
study the Percentage of patients with AF admitted with acute cerebrovascular stroke at Assuit University whatever those patients have manifest atrial fibrillation or go into attacks of paroxysmal atrial fibrillation by the use of echocardiography for measurement of left atrial diameter and size and also by the use of Holter to identify any any attacks of paroxysmal atrial fibrillation
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
correlation between AF and severity of stroke at admission and discharge.
Time Frame: 1 year
relation between presence of AF and severity of stroke by the use of NIH Stroke Score and MRS score at time of admission and discharge.
1 year
The role of anti coagulants in decreasing risk of ischemic cerebrovascular stroke in patients who are known to have Atrial Fibrillation and have been already anticoagulated
Time Frame: 1 year
if the anticoagulant intake decrease stroke severity in patients who are already taking anticoagulants by the use of NIH Stroke Score and MRS score at time of admission and discharge
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 1, 2020

Primary Completion (Anticipated)

January 1, 2021

Study Completion (Anticipated)

January 1, 2021

Study Registration Dates

First Submitted

September 18, 2019

First Submitted That Met QC Criteria

September 19, 2019

First Posted (Actual)

September 20, 2019

Study Record Updates

Last Update Posted (Actual)

September 25, 2019

Last Update Submitted That Met QC Criteria

September 23, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Atrial Fibrillation

Clinical Trials on echocardiography

3
Subscribe